• About Us
    • Our Company
    • Our People
  • Our Science
    • MediLink™ Platform
  • Pipeline
    • Overview
    • MFA011
    • MFA031
  • Partnering
  • News
  • Contact
  • About Us
    • Our Company
    • Our People
  • Our Science
    • MediLink™ Platform
  • Pipeline
    • Overview
    • MFA011
    • MFA031
  • Partnering
  • News

  • Contact

News

2026-05-22

MediMabBio Selected for KHIDI Boston C&D Incubation Program

2026-05-01

MediMabBio Selected for KHIDI Global Marketing Support Program

2025-11-10

MediMabBio Presents MFA031 Research at Cytokines 2025

2025-10-24

MediMabBio Secures KRW 25.6 Billion in Series B Funding to Advance Pipeline and Global Partnerships

2025-10-13

MediMabBio Wins 1st Place at Japan’s “Innovation Tiger 2025”

2025-04-25

MediMabBio Presents Promising Preclinical Data on aTIGIT-IL15 Fusion Antibody at AACR 2025

2025-03-20

MediMabBio Selected for “Bio-MPE Alliance Council” by Korea Biotechnology Industry Organization

2024-10-21

MediMabBio Selected for the “Korea-Singapore Technology Exchange and Investment Promotion Forum” Hosted by the Korea Techno-Venture Foundation

2024-08-27

MediMabBio Selected for 2024 Scale-Up TIPS Program

  • 1
  • 2
  • 3
  • »

  • Home
  • About Us
    • Our Company
    • Our People
  • Our Science
    • MediLink™ Platform
  • Pipeline
    • Overview
    • MFA011
    • MFA031
  • Partnering
  • News
  • Contact

#721, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13449 Tel. 82-(0)31-623-2100 Fax. 82-(0)31-751-2101 Email. info@medimabbio.com

©MEDIMABBIO. ALL RIGHTS RESERVED.